China's Compulsory Licenses — A Danger To Pharma Patents

Law360, New York (October 1, 2012, 1:26 PM EDT) -- The following issues are addressed in this article:

where to apply for compulsory license in China; how to select patents for compulsory license; what to say in compulsory license application; how much time the patent owner has to rebut; and whether a compulsory license will be stayed during appeal.

On March 15, 2012, the State Intellectual Property Office of China (SIPO) released a new version of compulsory patent license rules. The rules went into effect on May 1, 2012, and now provide a road map for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.